Literature DB >> 11779145

High levels of RAE-1 isoforms on mouse tumor cell lines assessed by anti-"pan" RAE-1 antibody confer tumor susceptibility to NK cells.

Hisayo Masuda1, Yoshiko Saeki, Midori Nomura, Kyoko Shida, Misako Matsumoto, Michio Ui, Lewis L Lanier, Tsukasa Seya.   

Abstract

Two sublines of the benzpyrene-induced mouse hepatoma cell line, G-1 and G-5, showed low and high metastatic ability, respectively, to the lung. We produced a polyclonal antibody (pAb) against RAE-1alpha. Five isoforms of RAE-1 have been identified to date, and this pAb recognized all isoforms and was named anti-"pan" RAE-1 pAb. The level of RAE-1 was approximately 5-fold higher in G-5 than in G-1, which was almost RAE-1-negative, as determined using anti-pan RAE-1 pAb. Expression levels of other markers including MHC class I (MHC-I) and Qa-1b were very low and indistinguishable in these sublines. NK-mediated cytotoxicity was determined with these sublines; G-5 was highly susceptible to NK-mediated cytolysis, while G-1 was relatively resistant. The NK-mediated G-5 > G-1 killing profile was diminished if the G-5 cells were pretreated with F(ab)(2)(') of anti-pan RAE-1 pAb. G-1, when transfected with Rae-1alpha cDNA, acquired NK-responsiveness similar to that of G-5. These and additional data using mouse cell lines with low MHC-I levels and various RAE-1 levels also demonstrated that RAE-1 level is critically associated with NK-susceptibility in tumor cells. (c)2002 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779145     DOI: 10.1006/bbrc.2001.6165

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors.

Authors:  Hiroaki Shime; Misako Matsumoto; Hiroyuki Oshiumi; Shinya Tanaka; Akio Nakane; Yoichiro Iwakura; Hideaki Tahara; Norimitsu Inoue; Tsukasa Seya
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-19       Impact factor: 11.205

2.  Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells.

Authors:  Takashi Akazawa; Takashi Ebihara; Manabu Okuno; Yu Okuda; Masashi Shingai; Kunio Tsujimura; Toshitada Takahashi; Masahito Ikawa; Masaru Okabe; Norimitsu Inoue; Miki Okamoto-Tanaka; Hiroyoshi Ishizaki; Jun Miyoshi; Misako Matsumoto; Tsukasa Seya
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-26       Impact factor: 11.205

3.  Obstructing shedding of the immunostimulatory MHC class I chain-related gene B prevents tumor formation.

Authors:  Jennifer D Wu; Catherine L Atteridge; Xuanjun Wang; Tsukasa Seya; Stephen R Plymate
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

4.  Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation.

Authors:  Takashi Ebihara; Masahiro Azuma; Hiroyuki Oshiumi; Jun Kasamatsu; Kazuya Iwabuchi; Kenji Matsumoto; Hirohisa Saito; Tadatsugu Taniguchi; Misako Matsumoto; Tsukasa Seya
Journal:  J Exp Med       Date:  2010-11-08       Impact factor: 14.307

5.  Development of a vaccine based on bacteria-mimicking tumor cells coated with novel engineered toll-like receptor 2 ligands.

Authors:  Takashi Akazawa; Toshimitsu Ohashi; Viskam Wijewardana; Kikuya Sugiura; Norimitsu Inoue
Journal:  Cancer Sci       Date:  2018-04-22       Impact factor: 6.716

6.  Elimination in vivo of developing T cells by natural killer cells.

Authors:  Eckart Schott; Roberto Bonasio; Hidde L Ploegh
Journal:  J Exp Med       Date:  2003-10-20       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.